Advertisement
Australia markets open in 2 hours 44 minutes

  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     

  • AUD/USD

    0.6425
    -0.0011 (-0.18%)
     

  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     

  • OIL

    82.51
    -0.18 (-0.22%)
     

  • GOLD

    2,394.40
    +6.00 (+0.25%)
     

  • Bitcoin AUD

    99,127.71
    +3,454.62 (+3.61%)
     

  • CMC Crypto 200

    1,311.43
    +425.90 (+92.66%)
     

J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine

Reuters
·1-min read

Sept 25 (Reuters) - Johnson & Johnson has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization said on Friday.

Michigan-based GRAM will manufacture the healthcare conglomerate's SARS-CoV-2 vaccine candidate, which is being developed with part funding from the U.S. government, and provide finished vials.

Earlier in the week, J&J launched a late-stage trial of its experimental single-shot COVID-19 vaccine and said its expects results of the trial by year end or early next year.

J&J, which is readying its supply chain to start distribution as soon as it gets FDA's approval, expects to manufacture as many as 1 billion doses in 2021. (Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)